⌘K

Login Start Free

Home/Filings/4/0001213900-19-011646

4//SEC Filing

Gabay Avraham 4

Accession 0001213900-19-011646

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 4:20 PM ET

Size

5.5 KB

Accession

0001213900-19-011646

Insider Transaction Report

Form 4

Period: 2019-06-17

ORAMED PHARMACEUTICALS INC.ORMP

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2019-06-17+33,146→ 33,146 total
Exercise: $3.55Exp: 2029-06-17→ Common Stock (33,146 underlying)

Footnotes (1)

[F1]The Stock Option will vest in 4 installments as follows: 5,396 shall vest on December 31, 2019; and 9,250 shall vest on each of December 31, 2020, December 31, 2021 and December 31, 2022.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001777328

Filing Metadata

Form type: 4
Filed: Jun 26, 8:00 PM ET
Accepted: Jun 27, 4:20 PM ET
Size: 5.5 KB

View on SEC.gov